Skip to main content
. 2021 Sep 14;14(12):101216. doi: 10.1016/j.tranon.2021.101216

Table 2.

Treatment summary of patients.

Treatment summary No. of patients Percent(%)
IC+IMRT+AC
PF 19 13.3
TPF 87 60.9
TP 4 2.8
GP 33 23.1
Chemotherapy cycles (IC)
1 3 2.1
2 136 95.1
3 4 2.8
Chemotherapy cycles (AC)
0 34 23.8
1 29 20.3
2 80 55.9